Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00827255 · ClinicalTrials.gov registry record
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 35
- Enrollment target
NCT00827255: Completed study, sponsored by Allergan.
NCT00827255 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00827255 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but discontinued use after less than 12 weeks of treatment.
Primary Outcome
Percentage of patients with complete clearing of corneal staining at month 12. Corneal staining is evaluated following administration of fluorescein dye into the eye. Complete clearing is defined as the absence of corneal staining.
Interventions
- DRUG Cyclosporine Ophthalmic Emulsion 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-10 |
What the finished NCT00827255 record still lists
NCT00827255 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cyclosporine Ophthalmic Emulsion 0.05% is the first listed.
NCT00827255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00827255 about?
NCT00827255 is a clinical study titled "Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%". The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but di...
What is the current status of trial NCT00827255?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2009-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00827255?
The interventions under investigation include: Cyclosporine Ophthalmic Emulsion 0.05% (DRUG).
Who is sponsoring clinical trial NCT00827255?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia